Hualan Bio | Briefing, News, Analysis, Research, Data

Hualan Bio

Hualan Bio genetic engineering vaccines and other high-tech products

Hualan Bio Vaccine is a modern vaccine manufacturer, mainly developing and producing human bacterial vaccines, viral vaccines, genetic engineering vaccines and other high-tech products. With advanced production equipment, testing laboratory, laboratory animal center and its affiliated facilities, it can meet the demand for vaccine products in epidemic-stricken areas in a short time.

Sector

Healthcare

Industry

Biotech/Pharma

Sub-industry

Founded

Mar 30, 1992

HQ location

Henan, China

Legal name

Hualan Biological Engineering,inc.

Website

http://www.hualanbio.com/

hualan@hualanbio.com

Employees

501-1000

All
News
Analysis
Research

Briefing Feb 16, 2023 12:51 PM · Healthcare

Innovative Drug Developer Rezu Bio Raised CNY 10 Mn in Series Pre-A

Briefing Feb 07, 2023 12:11 PM · Healthcare

ForLong Biotech Nets Over CNY 100 Mn in Series A

In-depth

Healthcare

Chinese Company Turned the Tables on Domestic Cell Culture Media Market

In this article, EqualOcean mainly introduce the history, competition, lead company, future trend in domestic cell culture media industry.

Feb 02, 2023 10:45 AM

Briefing Feb 07, 2023 10:59 AM · Healthcare

CytoCan Corp. Nets CNY 10 Mn in Seed Round

Briefing Jan 30, 2023 10:44 AM · Healthcare

Levostar Completes Pre-A Financing Round to Further Invest in CGT

Research

Healthcare

Digital Therapeutics - Revolution of the healthcare system

Nov 16, 2022 05:19 PM

Research

Healthcare

2022 China AI Health 30 Report

Nov 07, 2022 04:27 PM

Research

Healthcare

2022 China’s Healthcare Industry: An Introductory Handbook

Aug 29, 2022 05:45 PM

Research

Healthcare, Financials, Technology

WIA2020 | 30 Tech Entrepreneurs in China

Apr 22, 2021 03:11 PM

Briefing Jan 18, 2023 10:59 AM · Healthcare

BlissBio Nets Over CNY 100 Mn in Series B+

Briefing Sep 21, 2022 10:38 AM · Healthcare

Weiyou Gene Nets Tens of Millions of CNY in Series Pre-A Round

Briefing Sep 16, 2022 11:10 PM · Healthcare

NaviSeed Nets Tens of millions of CNY in Angel Round

Briefing Sep 13, 2022 05:30 PM · Healthcare

Nuwacell Nets Hundreds of Mns of CNY in Series A

Healthcare

BociMed Closed CNY 100 Mn in A New Financing Round

After this financing, BociMed will implement business restructuring and specify the focus of subsidiary and parent company

Feb 16, 2023 12:16 PM

Healthcare

Innovative Drug Developer Micot Nets Over CNY 100 Mn in Series C

The innovative drug company has raised over CNY 500 million to become a world-leading polypeptide drug developer

Feb 10, 2023 05:52 PM

Briefing Aug 31, 2022 08:30 PM · Healthcare

Enitiatebio Nets One Hundred Million of CNY in Series A Round

Briefing Jun 28, 2022 09:56 AM · Healthcare

And platinum medicine b7h4x4-1bb bispecific antibody were approved by FDA for new drug research

Briefing Jun 28, 2022 09:54 AM · Healthcare

Fosun pharma and Amgen have reached cooperation to accelerate the commercialization of two innovative drugs in China

Healthcare

Qiming-Backed Hochuen Medical Bags Over CNY 10 Mn in Series B Round

Microfluidics technology, at the core of point-of-care testing (POCT), has huge potential for growth.

Feb 08, 2023 04:50 PM

Healthcare

Hemay Pharmaceutical Nets Nearly CNY 300 Mn in Series D

The innovative drug company aims to provide more effective, affordable, safer medicine for patients

Feb 08, 2023 11:21 AM

Briefing Jun 28, 2022 09:50 AM · Healthcare

It is expected to achieve functional cure of chronic hepatitis B! GSK antisense therapy phase IIB positive clinical results

Briefing Jun 28, 2022 09:37 AM · Healthcare

Aibo biology: cooperate with Jiahe biology to jointly develop tumor mRNA drugs

Briefing Jun 24, 2022 11:15 AM · Healthcare

F-star to be acquired by China biopharmaceutical with USD 161million

Briefing Jun 24, 2022 11:07 AM · Healthcare

"Delisting warning" of Whitson pharmaceuticals on the New York Stock Exchange

EqualOcean Analysis